AI Verdict
IESC has stronger fundamentals based on our AI analysis.
IGC vs IESC Fundamental Comparison
| Metric | IGC | IESC |
|---|---|---|
| Revenue | $519,000.0 | $871.0M |
| Net Income | $-3.4M | $91.4M |
| Net Margin | -659.0% | 10.5% |
| ROE | -42.3% | 9.5% |
| ROA | -35.1% | 5.5% |
| Current Ratio | 1.32x | 1.80x |
| Debt/Equity | 0.02x | 0.00x |
| EPS | $-0.04 | $4.51 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
IGC vs IESC: Frequently Asked Questions
Is IGC or IESC a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), IESC has stronger fundamentals. IGC is rated STRONG SELL (85% confidence) while IESC is rated HOLD (68% confidence). This is not investment advice.
How does IGC compare to IESC fundamentally?
IGC Pharma, Inc. has ROE of -42.3% vs IES Holdings, Inc.'s 9.5%. Net margins are -659.0% vs 10.5% respectively.
Which stock pays higher dividends, IGC or IESC?
IGC has a dividend yield of N/A or no dividend while IESC has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in IGC or IESC for long term?
For long-term investing, consider that IGC has STRONG SELL rating with 85% confidence, while IESC has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about IGC vs IESC?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For IGC vs IESC, the AI consensus favors IESC based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.